Macrolide Resistance inTreponema pallidumin the United States and Ireland
Top Cited Papers
- 8 July 2004
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 351 (2) , 154-158
- https://doi.org/10.1056/nejmoa040216
Abstract
For decades, syphilis infection has been treated with penicillin, and Treponema pallidum has not developed resistance to penicillin. In many countries, the recommended treatment for early syphilis is a single dose of penicillin G benzathine, which maintains bactericidal levels for weeks, killing the slowly metabolizing treponemes. Azithromycin, which has a long tissue half-life and can be administered orally, was found to be effective in the treatment of syphilis in a rabbit model1 and in small studies in humans.2-6 Because of its convenience and efficacy, azithromycin is increasingly being used for the treatment of syphilis by clinicians and in disease-control activities in Canada and the United States, although it is not currently recommended by the Centers for Disease Control and Prevention.7Keywords
This publication has 17 references indexed in Scilit:
- Targeted mass treatment for syphilis with oral azithromycinThe Lancet, 2003
- A Randomized, Comparative Pilot Study of Azithromycin Versus Benzathine Penicillin G for Treatment of Early SyphilisSexually Transmitted Diseases, 2002
- Rapid Public Health Interventions in Response to an Outbreak of Syphilis in Los AngelesSexually Transmitted Diseases, 2002
- A Point Mutation Associated with Bacterial Macrolide Resistance Is Present in Both 23S rRNA Genes of an Erythromycin-Resistant Treponema pallidum Clinical Isolate Antimicrobial Agents and Chemotherapy, 2000
- Treatment of Early Syphilis with AzithromycinJournal of Chemotherapy, 2000
- Azithromycin Compared with Penicillin G Benzathine for Treatment of Incubating SyphilisAnnals of Internal Medicine, 1999
- Treatment of syphilis with azithromycinInternational Journal of STD & AIDS, 1996
- Pilot Study of Azithromycin for Treatment of Primary and Secondary SyphilisClinical Infectious Diseases, 1994
- Lomefloxacin-induced modification of the kinetics of growth of Gram-negative bacteria and susceptibility to phagocytic killing by human neutrophilsJournal of Antimicrobial Chemotherapy, 1990
- Treatment for early syphilis and reactivity of serologic testsJAMA, 1972